These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10899500)
1. Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Repronex SC, IVF Study Group. Gocial B; Keye WR; Fein SH; Nardi RV Fertil Steril; 2000 Jul; 74(1):73-9. PubMed ID: 10899500 [TBL] [Abstract][Full Text] [Related]
2. Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment. Nichols J; Knochenhauer E; Fein SH; Nardi RV; Marshall DC Fertil Steril; 2001 Jul; 76(1):58-66. PubMed ID: 11438320 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study. Dickey RP; Thornton M; Nichols J; Marshall DC; Fein SH; Nardi RV; Fertil Steril; 2002 Jun; 77(6):1202-8. PubMed ID: 12057729 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization. Keye WR; Webster B; Dickey R; Somkuti S; Crain J; Scobey MJ Reprod Biol Endocrinol; 2005 Nov; 3():62. PubMed ID: 16280073 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. Keye WR; Marrs RP; Check JH; Schnell V; Surrey M; Marshall DC; Fertil Steril; 2004 Aug; 82(2):348-57. PubMed ID: 15302283 [TBL] [Abstract][Full Text] [Related]
6. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection. Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022 [TBL] [Abstract][Full Text] [Related]
7. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Branigan EF; Estes MA Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017 [TBL] [Abstract][Full Text] [Related]
8. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response. Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988 [TBL] [Abstract][Full Text] [Related]
9. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329 [TBL] [Abstract][Full Text] [Related]
10. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer. Huang JC; Jackson KV; Hornstein MD; Ginsburg ES J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120 [TBL] [Abstract][Full Text] [Related]
11. High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer. Barash OO; Hinckley MD; Rosenbluth EM; Ivani KA; Weckstein LN Hum Reprod; 2017 Nov; 32(11):2209-2217. PubMed ID: 29040519 [TBL] [Abstract][Full Text] [Related]
12. Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles. Martin KA; Hornstein MD; Taylor AE; Hall JE; Barbieri RL Fertil Steril; 1997 Dec; 68(6):1011-6. PubMed ID: 9418689 [TBL] [Abstract][Full Text] [Related]
13. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer]. Wang L; Zhang WX; Jiang H Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190 [TBL] [Abstract][Full Text] [Related]
14. Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization. Dickey RP; Nichols JE; Steinkampf MP; Gocial B; Thornton M; Webster BW; Bello SM; Crain J; Marshall DC; Reprod Biol Endocrinol; 2003 Oct; 1():63. PubMed ID: 14609434 [TBL] [Abstract][Full Text] [Related]
15. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation]. Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561 [TBL] [Abstract][Full Text] [Related]
16. Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program. Hsieh Y; Tsai H; Chang C; Lo H Fertil Steril; 2000 Apr; 73(4):817-20. PubMed ID: 10731546 [TBL] [Abstract][Full Text] [Related]
17. Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study. Orvieto R; Kerner R; Krissi H; Ashkenazi J; Ben Rafael Z; Bar-Hava I Fertil Steril; 2002 Dec; 78(6):1268-71. PubMed ID: 12477523 [TBL] [Abstract][Full Text] [Related]
19. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization. Jiang S; Kuang Y Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429 [TBL] [Abstract][Full Text] [Related]
20. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist. Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]